Lexicon Pharmaceuticals
LXRX
#7254
Rang
€0.40 Md
Capitalisation boursière
1,12 €
Prix de l'action
-0.38%
Changement (1 jour)
62.00%
Changement (1 an)

Lexicon Pharmaceuticals (LXRX) - Dette totale

Dette totale au bilan au Septembre 2025 : 49.64 Millions d'euros

Selon les derniers rapports financiers de Lexicon Pharmaceuticals , la dette totale de l'entreprise est de 49.64 Millions d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Lexicon Pharmaceuticals - Dette totale au bilan (de 2000 à 2025)

Dette totale par année

Année Dette totale Changement
2024-12-31€0.10 Md8.57%
2023-12-31€95.94 M86.13%
2022-12-31€51.54 M2461.56%
2021-12-31€2.01 M-80.68%
2020-12-31€10.41 M-95.25%
2019-12-31€0.21 Md2.43%
2018-12-31€0.21 Md4.6%
2017-12-31€0.20 Md112.29%
2016-12-31€96.44 M2.45%
2015-12-31€94.14 M6.34%
2014-12-31€88.52 M458.84%
2013-12-31€15.84 M-10.65%
2012-12-31€17.72 M-7.51%
2011-12-31€19.16 M-10.48%
2010-12-31€21.41 M-54.18%
2009-12-31€46.73 M114.29%
2008-12-31€21.81 M1.51%
2007-12-31€21.48 M-11.92%
2006-12-31€24.39 M-21.77%
2005-12-31€31.18 M12.41%
2004-12-31€27.74 M-38.01%
2003-12-31€44.75 M1069.56%
2002-12-31€3.82 M
2000-12-31€3.02 M-36.38%
1999-12-31€4.74 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Eterna Therapeutics
ERNA
€0.47 M-99.05%🇺🇸 USA
Regeneron Pharmaceuticals
REGN
€2.30 Md 4,552.62%🇺🇸 USA
Ultragenyx Pharmaceutical
RARE
€28.88 M-41.82%🇺🇸 USA
BioMarin Pharmaceutical
BMRN
€0.51 Md 939.11%🇺🇸 USA
Thermo Fisher Scientific
TMO
€30.46 Md 61,258.56%🇺🇸 USA
Esperion Therapeutics
ESPR
€0.26 Md 427.59%🇺🇸 USA
Illumina
ILMN
€2.19 Md 4,329.92%🇺🇸 USA
Ligand Pharmaceuticals
LGND
€0.38 Md 675.58%🇺🇸 USA
Aerie Pharmaceuticals
AERI
€0.28 Md 479.51%🇺🇸 USA